SCHEMBL993010

SCHEMBL993010

C(CN1CCNCC1)CN1CCNCC1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 3/20 0.73
POLB P06746 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
SIGMAR1 Q99720 2/20 0.54
KDM1A O60341 1/20 0.48
HSD17B10 Q99714 1/20 0.46
CHRM2 P08172 1/20 0.46
CHRM4 P08173 1/20 0.46
CHRM5 P08912 1/20 0.46
CHRM1 P11229 1/20 0.46
CHRM3 P20309 1/20 0.46
RAD52 P43351 1/20 0.43
HRH3 Q9Y5N1 2/20 0.42
HRH2 P25021 1/20 0.42
HRH1 P35367 1/20 0.42
GNAI3 P08754 3/20 0.41
GNAO1 P09471 3/20 0.41
GNAI1 P63096 3/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5570598 0.97 CXCR4 (0.70) CXCR4POLBSMN1; SMN2SIGMAR1KDM1A
SCHEMBL1843440 0.97 CXCR4 (0.77) CXCR4POLBSMN1; SMN2SIGMAR1KDM1A
SCHEMBL8614873 0.94 CXCR4 (0.70) CXCR4POLBSMN1; SMN2SIGMAR1KDM1A
SCHEMBL3992323 0.92 CXCR4 (0.78) CXCR4POLBSMN1; SMN2SIGMAR1KDM1A
SCHEMBL1934187 0.92 CXCR4 (0.78) CXCR4POLBSMN1; SMN2SIGMAR1KDM1A
SCHEMBL11726023 0.91 CXCR4 (0.74) CXCR4POLBSMN1; SMN2SIGMAR1KDM1A
Hydrochloric Acid SCHEMBL5570648 0.91 CXCR4 (0.67) CXCR4POLBSMN1; SMN2SIGMAR1KDM1A
SCHEMBL1841507 0.91 CXCR4 (0.74) CXCR4POLBSMN1; SMN2SIGMAR1KDM1A
SCHEMBL21569302 0.91 CXCR4 (0.74) CXCR4POLBSMN1; SMN2SIGMAR1KDM1A
SCHEMBL11721752 0.91 CXCR4 (0.74) CXCR4POLBSMN1; SMN2SIGMAR1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5612448-A POLYAMIDES WITH HIGH STRENGTH AND FLEXIBILITY UNION CAMP CORPORATION (US) 1997-03-18 US claimed
EP-0721473-A4 CURABLE ADHESIVE COMPOSITIONS CONTAINING POLYAMIDE RESINS UNION CAMP CORP (US) 1996-09-25 EP claimed
EP-0721473-A1 CURABLE ADHESIVE COMPOSITIONS CONTAINING POLYAMIDE RESINS Union Camp Corporation (US) 1996-07-17 EP claimed
EP-0442700-B1 Two-component curable hot-melt resin compositions UNION CAMP CORP (US) 1996-01-03 EP claimed
EP-0356208-B1 Membrane filter material having excellent organic solvent resistance, method for formation of membrane filter and process for preparation of bismaleimide polymer to be used for membrane filter MITSUI PETROCHEMICAL IND (JP) 1995-05-24 EP claimed
WO-1995009189-A1 CURABLE ADHESIVE COMPOSITIONS CONTAINING POLYAMIDE RESINS UNION CAMP CORPORATION (US) 1995-04-06 WO claimed
US-5385986-A Improved cohesion, adhesion, ductility, flexibility; heat, solvent and moisture resistance; curable UNION CAMP CORPORATION (US) 1995-01-31 US claimed
EP-0442700-A2 Two-component curable hot-melt resin compositions UNION CAMP CORPORATION (US) 1991-08-21 EP claimed
EP-0441545-A1 Two-component curable hot-melt resin compositions Union Camp Corporation (US) 1991-08-14 EP claimed
US-5035802-A Membrane filter material having excellent organic solvent resistance, method for formation of membrane filter and process for preparation of bismaleimide polymer to be used for membrane filter MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1991-07-30 US claimed
EP-0356208-A2 Membrane filter material having excellent organic solvent resistance, method for formation of membrane filter and process for preparation of bismaleimide polymer to be used for membrane filter MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1990-02-28 EP claimed
EP-0227043-A2 Composite semipermeable membrane and process for producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-07-01 EP claimed
JP-2056227-A None JP disclosed
WO-2023167201-A1 ACTIVE ENERGY RAY-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT 株式会社カネカ 2023-09-07 WO disclosed
CN-109415447-B Silane-mediated enhancement of rubber storage stability 盛禧奥欧洲有限责任公司 2021-06-15 CN disclosed
US-10858377-B2 Multivinylaminosilanes as branching agents for functionalized elastomeric polymers TRINSEO EUROPE GMBH (CH) 2020-12-08 US disclosed
EP-0082983-A1 Curable synthetic resin compositions and agents for curable synthetic resin compositions based on prepolymeric polyether-urethane-urea amines and epoxide resins an/or aromatic carbamic-acid aryl esters SCHERING AKTIENGESELLSCHAFT (DE) 1983-07-06 EP disclosed
EP-0061782-A2 Composite semipermeable membrane and process for preparation thereof NITTO ELECTRIC INDUSTRIAL CO., LTD. (JP) 1982-10-06 EP disclosed
US-4059549-A POLYURETHANE, ENAMINE SCHERING AKTIENGESELLSCHAFT (DT) 1977-11-22 US disclosed
US-3963680-A CURING CATALYSTS, POLYFUNCTIONAL AMINE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1976-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10858377-B2 Multivinylaminosilanes as branching agents for functionalized elastomeric polymers GMNN, GNE, MSN CXCR4 3986/4885POLB 1534/4885SMN1; SMN2 713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.